Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained
- PMID: 11095272
- DOI: 10.1016/S0140-6736(00)03215-3
Implications of trial results: the potentially misleading notions of number needed to treat and average duration of life gained
Abstract
Consider a physician advising a patient to start antihypertensive treatment. He has the unenviable task of presenting often conflicting trial data in a comprehensible manner. He must justly represent the known risks and benefits such that his patient can make a reasonably Informed choice. Should the physician cite the number needed to treat or the average duration of life gained to clarify his explanations?
Comment in
-
Losartan for cardiovascular disease in patients with and without diabetes in the LIFE study.Lancet. 2002 Jun 22;359(9324):2199; author reply 2203-4. doi: 10.1016/S0140-6736(02)09068-2. Lancet. 2002. PMID: 12091001 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
